Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Novartis
Woman and Man Max 99 years
Novartis Vaccines and Diagnostics Srl
Update Il y a 4 ans
Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months
To evaluate the immunogenicity of two 0.25 mL IM doses of Fluad or Fluzone influenza vaccines in terms of post-vaccination geometric mean titers (GMTs), seroprotection rates and seroconversion rates, ...
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
Novartis Pharma Services
Update Il y a 4 ans
A phase III multi-center, open-label, randomized study of the efficacy of nilotinib versus imatinib in adult patients with Philadelphia chromosome positive (Ph+ ) chronic myelogenous leukemia in chronic phase (CML - CP) who have suboptimal cytogenetic response (CyR) on imatinib
To evaluate the complete cytogenetic response (CCyR ) rate at 12 months of nilotinib compared to imatinib in adult patients with Ph+ CML in CP who have a suboptimal cytogenetic response to imatinib.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 4 ans
Efficacy and safety study of QAW039 in the treatment of patients with moderate to severe atopic dermatitis
The purpose of this study is to determine whether QAW039 is safe and has beneficial effects in people who have moderate to severe atopic dermatitis (AD) - Eczema Area and Severity Index (EASI) sco...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 4 ans
A multicenter, double-blind, randomized study to compare the efficacy of 24 weeks treatment with fixed combination therapy of vildagliptin and metformin (25/1000 mg bid) versus metformin monotherapy (1000 mg bid) in patients with type 2 diabetes inadequately controlled with metformin monotherapy
To demonstrate that the HbA1c reduction with fixed dose combination therapy of vildagliptin and metformin (25/1000 mg bid) is superior to that with metformin monotherapy (1000 mg bid) after 24 weeks o...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 4 ans
A study to check how safe, beneficial and tolerable the drug canakinumab, along with childhood vaccines, is for patients with crypoyrin associated periodic syndromes (CAPS)
To assess the long-term efficacy of canakinumab with respect to the maintenance of treatment response in CAPS patients who completed the CACZ885D2307 study
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Farmacéutica, S. A
Update Il y a 4 ans
Estudio multicéntrico, aleatorizado, ciego, controlado con placebo de 3 meses de duración para evaluar el efecto del tratamiento con fingolimod en la respuesta inmune después de la vacuna para la gripe estacional y la dosis de recuerdo de vacuna antitetánica en pacientes con formas recidivantes de esclerosis múltiple
Es un estudio de investigación clínica para averiguar si el fármaco fingolimod (FTY729) es seguro en personas que padezcan esclerosis múltiple (EM) y que tengan previsto vacunarse contra la gripe esta...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma GmbH
Update Il y a 4 ans
Study in patients with moderate to severe psoriasis with secukinumab
To demonstrate that secukinumab has superior efficacy compared to placebo on the pruritus intensity VAS (the worst itching within a recall period of 24 hours as part of the Patients Global Assessment ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Novartis Pharma Services AG
Update Il y a 4 ans
Evaluation of drug-drug interaction between LCZ696 and sildenafil in subjects with mild to moderate hypertension
- To investigate the effect of LCZ696 on single dose pharmacokinetics of sildenafil in subjects with mild to moderate hypertension. - To investigate the effect of sildenafil on the steady-state pharm...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 4 ans
Study to evaluate treatment compliance, efficacy and safety of an improved deferasirox formulation (granules) in pediatric patients (2-<18 years old) with iron overload A deferazirox továbbfejlesztett gyógyszerformájának (granulátum) hatásosságát és biztonságosságát, valamint a kezeléssel való együttműködést értékelő vizsgálat vastúlterhelésben szenvedő (2 ‒ < 18 éves) gyermekeknél
1. To evaluate both formulations on patient compliance, using stick pack/tablet count in ICT naive patients 2. To evaluate the change from baseline in serum ferritin at 48 weeks of treatment for both...
Country
None
organs
None
Specialty
None
unknown
More information
Woman Max 99 years
Novartis Pharma Services AG
Update Il y a 4 ans
An expanded access study for postmenopausal women with estrogen receptor positive locally advanced or metastatic breast cancer who have progressed following prior endocrine therapy, investigating the treatment of everolimus (RAD001) in combination with exemestane
to evaluate safety of everolimus (RAD001) in postmenopausal women with hormone receptor positive locally advanced or metastatic breast cancer after recurrence or progression following NSAIs treatment
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
4
5
6
7
8
9
10
Next